Bendamax is a chemotherapy medication used in the treatment of certain cancers, including chronic lymphocytic leukemia (CLL) and non-Hodgkin's lymphoma (NHL). It belongs to the class of drugs known as alkylating agents and is available as an injection for intravenous use. Bendamax works by damaging the DNA of cancer cells, which prevents them from dividing and leads to their destruction. This dual-action mechanism-alkylation and disruption of DNA repair pathways-makes it effective in targeting rapidly growing cancer cells.

Indications:

• Chronic Lymphocytic Leukemia (CLL)
• Indolent Non-Hodgkin's Lymphoma (iNHL) that has not responded to other treatments
• Off-label uses as determined by oncologists